Journal for ImmunoTherapy of Cancer (Nov 2020)
244 Novel respirable antisense oligonucleotide (RASON) approach to primary and metastatic human lung cancer: preliminary results in a model system employing spontaneous lung tumors in dogs
Abstract
No abstracts available.